58 related articles for article (PubMed ID: 3778556)
21. [The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain].
Gankina EM; Porodenko NV; Kondratenko TI; Severin ES; Kaminka ME; Mashkovskiĭ MD
Eksp Klin Farmakol; 1993; 56(1):22-4. PubMed ID: 8100727
[TBL] [Abstract][Full Text] [Related]
22. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis.
Bellanger C; Halm MP; Dauphin F; Chichery R
Neurosci Lett; 2005 Oct; 387(3):162-7. PubMed ID: 16026931
[TBL] [Abstract][Full Text] [Related]
23. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain.
Terry AV; Gearhart DA; Mahadik SP; Warsi S; Waller JL
Neuroscience; 2006 Jul; 140(4):1277-87. PubMed ID: 16626873
[TBL] [Abstract][Full Text] [Related]
24. Neonatal ethanol exposure to rat pups: resultant alterations of cortical muscarinic and cerebellar H1-histaminergic receptor binding dynamics.
Serbus DC; Stull RE; Light KE
Neurotoxicology; 1986; 7(2):257-78. PubMed ID: 3785752
[No Abstract] [Full Text] [Related]
25. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
Peroutka SJ; Snyder SH
J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
[TBL] [Abstract][Full Text] [Related]
26. [3H]Nicotine binding sites in developing fetal brains in rats.
Sugiyama H; Hagino N; Moore G; Lee JW
Neurosci Res; 1985 Jun; 2(5):387-92. PubMed ID: 4034103
[TBL] [Abstract][Full Text] [Related]
27. Evidence for an involvement of acetylcholine in self-stimulation of the prefrontal cortex in the rat.
Mora F; Vives F; Alba F
Experientia; 1980 Oct; 36(10):1180-1. PubMed ID: 7418797
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties.
Punzi JS; Banerjee S; Abood LG
Biochem Pharmacol; 1991 Feb; 41(3):465-7. PubMed ID: 1994905
[No Abstract] [Full Text] [Related]
29. In vitro and in vivo evidence for the existence of presynaptic muscarinic cholinergic receptors in the rat hippocampus.
Consolo S; Wang JX; Fusi R; Vinci R; Forloni G; Ladinsky H
Brain Res; 1984 Aug; 309(1):147-51. PubMed ID: 6488003
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous receptor binding of classical quaternary muscarinic antagonists. II. Modulation in bovine brain.
Roffel AF; Ensing K; Elzinga CR; in 't Hout WG; van Tintelen EJ; de Zeeuw RA; Zaagsma J
Arch Int Pharmacodyn Ther; 1991; 314():105-21. PubMed ID: 1824185
[TBL] [Abstract][Full Text] [Related]
31. Acute and subchronic corticosterone treatment differentially modulates subcortical limbic and neostriatal nicotinic cholinergic receptors.
von Euler G; Fuxe K; Finnman UB; Agnati LF
Brain Res; 1990 Aug; 526(1):122-6. PubMed ID: 2078812
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.
Wilson AA; Dannals RF; Ravert HT; Frost JJ; Wagner HN
J Med Chem; 1989 May; 32(5):1057-62. PubMed ID: 2785211
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the involvement of central muscarinic cholinergic & H2-histaminergic receptors in morphine induced hyperactivity in the mouse.
Pant KK; Gurtu S; Nath C; Sinha JN; Bhargava KP
Indian J Med Res; 1983 Oct; 78():587-92. PubMed ID: 6668016
[No Abstract] [Full Text] [Related]
34. The effect of mepyramine on the development of morphine tolerance and physical dependence in mice.
Hui KS; Roberts MB
Life Sci; 1975 Sep; 17(6):891-9. PubMed ID: 1238888
[No Abstract] [Full Text] [Related]
35. Negative inotropic activity of antilaminin IgG: participation of cholinergic mechanisms.
Bacman S; Borda E; Denduchis B; Lustig L; Sterin-Borda L
Br J Pharmacol; 1989 Jun; 97(2):377-82. PubMed ID: 2758220
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine.
Clarke PB
Biochem Pharmacol; 1990 Oct; 40(7):1427-32. PubMed ID: 2222501
[No Abstract] [Full Text] [Related]
37. H1 antihistamines interact with central sigma receptors.
Gray NM; Contreras PC; Allen SE; Taylor DP
Life Sci; 1990; 47(2):175-80. PubMed ID: 1975080
[TBL] [Abstract][Full Text] [Related]
38. Profile of in vitro binding affinities of neuroleptics at different rat brain receptors: cluster analysis comparison with pharmacological and clinical profiles.
Testa R; Abbiati G; Ceserani R; Restelli G; Vanasia A; Barone D; Gobbi M; Mennini T
Pharm Res; 1989 Jul; 6(7):571-7. PubMed ID: 2571988
[TBL] [Abstract][Full Text] [Related]
39. The clinical use of beta-2-pyridylalkylamines. II. Treatment of histaminic cephalgia (Horton's headache) with a note on angina pectoris.
HORTON BT
Proc Staff Meet Mayo Clin; 1962 Dec; 37():713-23. PubMed ID: 13964044
[No Abstract] [Full Text] [Related]
40. Brain nicotine binding sites.
Wonnacott S
Hum Toxicol; 1987 Sep; 6(5):343-53. PubMed ID: 3315965
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
